These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

845 related items for PubMed ID: 22547072

  • 1. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity.
    Ladiwala AR, Litt J, Kane RS, Aucoin DS, Smith SO, Ranjan S, Davis J, Van Nostrand WE, Tessier PM.
    J Biol Chem; 2012 Jul 13; 287(29):24765-73. PubMed ID: 22547072
    [Abstract] [Full Text] [Related]

  • 2. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
    Wu JW, Breydo L, Isas JM, Lee J, Kuznetsov YG, Langen R, Glabe C.
    J Biol Chem; 2010 Feb 26; 285(9):6071-9. PubMed ID: 20018889
    [Abstract] [Full Text] [Related]

  • 3. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A, Luheshi LM, Söllvander S, Pereira de Barros T, Macao B, Knowles TP, Biverstål H, Lendel C, Ekholm-Petterson F, Dubnovitsky A, Lannfelt L, Dobson CM, Härd T.
    Proc Natl Acad Sci U S A; 2010 Aug 31; 107(35):15595-600. PubMed ID: 20713699
    [Abstract] [Full Text] [Related]

  • 4. Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.
    Romeo M, Stravalaci M, Beeg M, Rossi A, Fiordaliso F, Corbelli A, Salmona M, Gobbi M, Cagnotto A, Diomede L.
    J Alzheimers Dis; 2017 Aug 31; 57(3):857-871. PubMed ID: 28282805
    [Abstract] [Full Text] [Related]

  • 5. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.
    Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M, Margol L, Wu J, Breydo L, Thompson JL, Rasool S, Gurlo T, Butler P, Glabe CG.
    Mol Neurodegener; 2007 Sep 26; 2():18. PubMed ID: 17897471
    [Abstract] [Full Text] [Related]

  • 6. Conformation-specific perturbation of membrane dynamics by structurally distinct oligomers of Alzheimer's amyloid-β peptide.
    Madhu P, Das D, Mukhopadhyay S.
    Phys Chem Chem Phys; 2021 Apr 28; 23(16):9686-9694. PubMed ID: 33908427
    [Abstract] [Full Text] [Related]

  • 7. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B, Bonet J, Valls-Comamala V, Bosch-Morató M, Godoy JA, Inestrosa NC, Perálvarez-Marín A, Fernández-Busquets X, Andreu D, Oliva B, Muñoz FJ.
    J Neurosci; 2016 Nov 16; 36(46):11693-11703. PubMed ID: 27852777
    [Abstract] [Full Text] [Related]

  • 8. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ, Chen YR.
    FEBS J; 2014 Jun 16; 281(11):2674-87. PubMed ID: 24720730
    [Abstract] [Full Text] [Related]

  • 9. Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity.
    Ono K, Condron MM, Teplow DB.
    J Biol Chem; 2010 Jul 23; 285(30):23186-97. PubMed ID: 20452980
    [Abstract] [Full Text] [Related]

  • 10. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway.
    Lee S, Fernandez EJ, Good TA.
    Protein Sci; 2007 Apr 23; 16(4):723-32. PubMed ID: 17327396
    [Abstract] [Full Text] [Related]

  • 11. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
    Goldblatt G, Cilenti L, Matos JO, Lee B, Ciaffone N, Wang QX, Tetard L, Teter K, Tatulian SA.
    FEBS J; 2017 May 23; 284(9):1355-1369. PubMed ID: 28294556
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Structure-neurotoxicity relationships of amyloid beta-protein oligomers.
    Ono K, Condron MM, Teplow DB.
    Proc Natl Acad Sci U S A; 2009 Sep 01; 106(35):14745-50. PubMed ID: 19706468
    [Abstract] [Full Text] [Related]

  • 19. Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.
    Ladiwala AR, Mora-Pale M, Lin JC, Bale SS, Fishman ZS, Dordick JS, Tessier PM.
    Chembiochem; 2011 Jul 25; 12(11):1749-58. PubMed ID: 21671331
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.